1. Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer. Issue 10 (18th August 2021) Authors: Martens‐Uzunova, Elena S.; Kusuma, Gina D.; Crucitta, Stefania; Lim, Hong Kiat; Cooper, Crystal; Riches, James E.; Azad, Arun; Ochiya, Takahiro; Boyle, Glen M.; Southey, Melissa C.; Del Re, Marzia; Lim, Rebecca; Ramm, Grant A.; Jenster, Guido W.; Soekmadji, Carolina Journal: Journal of extracellular vesicles Issue: Volume 10:Issue 10(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis. Issue 6 (30th January 2022) Authors: Chazan, Grace; Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond M; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Gibbs, Peter; Tran, Ben Journal: Asia-Pacific journal of clinical oncology Issue: Volume 18:Issue 6(2022) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial. Issue 1 (December 2016) Authors: Leibowitz-Amit, Raya; Pintilie, Melania; Khoja, Leila; Azad, Arun; Berger, Raanan; Laird, A.; Aftab, Dana; Chi, Kim; Joshua, Anthony Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Continuous Flow Deformability‐Based Separation of Circulating Tumor Cells Using Microfluidic Ratchets. Issue 14 (24th February 2016) Authors: Park, Emily S.; Jin, Chao; Guo, Quan; Ang, Richard R.; Duffy, Simon P.; Matthews, Kerryn; Azad, Arun; Abdi, Hamidreza; Todenhöfer, Tilman; Bazov, Jenny; Chi, Kim N.; Black, Peter C.; Ma, Hongshen Journal: Small Issue: Volume 12:Issue 14(2016) Page Start: 1909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ENZA‐p trial protocol: a randomized phase II trial using prostate‐specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration‐resistant prostate cancer treated with enzalutamide (ANZUP 1901). (6th July 2021) Authors: Emmett, Louise; Subramaniam, Shalini; Joshua, Anthony M.; Crumbaker, Megan; Martin, Andrew; Zhang, Alison Y.; Rana, Nisha; Langford, Ailsa; Mitchell, Jenna; Yip, Sonia; Francis, Roslyn; Hofman, Michael S.; Sandhu, Shahneen; Azad, Arun; Gedye, Craig; McJannett, Margaret; Stockler, Martin R.; Davis... Journal: BJU international Issue: Volume 128:Number 5(2021) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients. Issue 1 (December 2016) Authors: Lallous, Nada; Volik, Stanislav; Awrey, Shannon; Leblanc, Eric; Tse, Ronnie; Murillo, Josef; Singh, Kriti; Azad, Arun; Wyatt, Alexander; LeBihan, Stephane; Chi, Kim; Gleave, Martin; Rennie, Paul; Collins, Colin; Cherkasov, Artem Journal: Genome biology Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities. Issue 5 (15th September 2022) Authors: Rinott Mizrahi, Gal; Williams, Isabella; Azad, Arun; Lawrentschuk, Nathan Journal: Current opinion in urology Issue: Volume 32:Issue 5(2022) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Going nuclear: it is time to embed the nuclear medicine physician in the prostate cancer multidisciplinary team. (16th July 2019) Authors: Murphy, Declan G.; Hofman, Michael S.; Azad, Arun; Violet, John; Hicks, Rodney J.; Lawrentschuk, Nathan Journal: BJU international Issue: Volume 124:Number 4(2019) Page Start: 551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?. (September 2019) Authors: Alipour, Ramin; Azad, Arun; Hofman, Michael S. Journal: Therapeutic advances in medical oncology Issue: Volume 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Local and systemic modulation of the PD-L1 pathway is a novel mechanism of Enzalutamide resistance in castration-resistant prostate cancer. (6th November 2014) Authors: Bishop, Jennifer; Sio, Alexander; Angeles, Arkhjamil; Roberts, Morgan; Azad, Arun; Chi, Kim; Zoubeidi, Amina Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗